ARK Genomic Revolution ETF (BATS:ARKG) Shares Bought by Sloy Dahl & Holst LLC

Sloy Dahl & Holst LLC boosted its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 18.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,492 shares of the company’s stock after acquiring an additional 2,079 shares during the period. Sloy Dahl & Holst LLC’s holdings in ARK Genomic Revolution ETF were worth $443,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Elmwood Wealth Management Inc. purchased a new stake in shares of ARK Genomic Revolution ETF during the fourth quarter worth about $302,000. DHK Financial Advisors Inc. grew its holdings in shares of ARK Genomic Revolution ETF by 124.2% during the fourth quarter. DHK Financial Advisors Inc. now owns 44,410 shares of the company’s stock worth $1,457,000 after buying an additional 24,600 shares in the last quarter. Perigon Wealth Management LLC grew its holdings in shares of ARK Genomic Revolution ETF by 12.9% during the fourth quarter. Perigon Wealth Management LLC now owns 29,583 shares of the company’s stock worth $971,000 after buying an additional 3,380 shares in the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of ARK Genomic Revolution ETF by 20.8% during the fourth quarter. Geneos Wealth Management Inc. now owns 9,726 shares of the company’s stock worth $319,000 after buying an additional 1,677 shares in the last quarter. Finally, International Assets Investment Management LLC grew its holdings in shares of ARK Genomic Revolution ETF by 120.1% during the fourth quarter. International Assets Investment Management LLC now owns 107,617 shares of the company’s stock worth $3,280,000 after buying an additional 58,715 shares in the last quarter.

ARK Genomic Revolution ETF Price Performance

Shares of BATS ARKG traded down $0.79 during midday trading on Wednesday, reaching $24.11. 3,718,870 shares of the stock were exchanged. The stock’s 50-day simple moving average is $29.19 and its 200 day simple moving average is $28.53.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.